{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:30Z","timestamp":1791910410904,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011840","name":"Shantou University Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118382","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:42:33Z","timestamp":1787388153000},"page":"118382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Dapagliflozin attenuates cellular senescence and mitochondrial dysfunction in diabetic kidney disease: potential involvement of AMPK\/Sirt3 signaling"],"prefix":"10.1016","volume":"253","author":[{"given":"Xin","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0532-3684","authenticated-orcid":false,"given":"Weiyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2026.118382_b0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc23-2364","article-title":"The difference between cystatin C- and creatinine-based estimated glomerular filtration rate and risk of diabetic microvascular complications among adults with diabetes: a population-based cohort study","volume":"47","author":"He","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2026.118382_b0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cegh.2020.05.016","article-title":"Diabetic kidney disease: an overview of prevalence, risk factors, and biomarkers","volume":"9","author":"Hussain","year":"2021","journal-title":"Clinical Epidemiology and Global Health"},{"key":"10.1016\/j.bcp.2026.118382_b0015","article-title":"Mechanisms of diabetic kidney disease and established and emerging treatments","author":"Martinez Leon","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118382_b0020","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2337\/db25-0417","article-title":"NUAK1 promotes diabetic kidney disease by accelerating renal tubular senescence via the ROS\/P53 axis","volume":"74","author":"Guo","year":"2025","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2026.118382_b0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00125-022-05810-6","article-title":"Hedgehog interacting protein activates sodium-glucose cotransporter 2 expression and promotes renal tubular epithelial cell senescence in a mouse model of type 1 diabetes","volume":"66","author":"Zhao","year":"2023","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.bcp.2026.118382_b0030","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1038\/s41467-022-32477-9","article-title":"Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression","volume":"13","author":"Al-Dabet","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2026.118382_b0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","article-title":"Cellular senescence: the good, the bad and the unknown","volume":"18","author":"Huang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"31","key":"10.1016\/j.bcp.2026.118382_b0040","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/eurheartj\/ehz919","article-title":"Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis","volume":"41","author":"Stojanovi\u0107","year":"2020","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.bcp.2026.118382_b0045","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcp.2026.118382_b0050","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrd.2017.116","article-title":"Senescent cells: an emerging target for diseases of ageing","volume":"16","author":"Childs","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2026.118382_b0055","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1038\/s41467-024-52214-8","article-title":"Factor XII signaling via uPAR-integrin \u03b21 axis promotes tubular senescence in diabetic kidney disease","volume":"15","author":"Elwakiel","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2026.118382_b0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.kint.2021.06.031","article-title":"The ketone body \u03b2-hydroxybutyrate mitigates the senescence response of glomerular podocytes to diabetic insults","volume":"100","author":"Fang","year":"2021","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.bcp.2026.118382_b0065","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1681\/ASN.2020091373","article-title":"Progressive cellular senescence mediates renal dysfunction in ischemic nephropathy","volume":"32","author":"Kim","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"594","key":"10.1016\/j.bcp.2026.118382_b0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0203","article-title":"Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair","volume":"13","author":"Mylonas","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"13","key":"10.1016\/j.bcp.2026.118382_b0075","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158447","article-title":"Mitochondrial dysfunction in cell senescence and aging","volume":"132","author":"Miwa","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118382_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.671908","article-title":"The role of mitochondrial dysfunction in vascular disease, tumorigenesis, and diabetes","volume":"8","author":"Zhunina","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"7983","key":"10.1016\/j.bcp.2026.118382_b0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","article-title":"Apoptotic stress causes mtDNA release during senescence and drives the SASP","volume":"622","author":"Victorelli","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2026.118382_b0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41581-024-00806-4","article-title":"Sirtuins in kidney health and disease","volume":"20","author":"Perico","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118382_b0095","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1093\/nar\/gkab161","article-title":"SIRT3 consolidates heterochromatin and counteracts senescence","volume":"49","author":"Diao","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.118382_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101915","article-title":"Sirt3-mediated mitophagy regulates AGEs-induced BMSCs senescence and senile osteoporosis","volume":"41","author":"Guo","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118382_b0105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41392-022-01254-x","article-title":"FFAR4 improves the senescence of tubular epithelial cells by AMPK\/SirT3 signaling in acute kidney injury","volume":"7","author":"Yang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118382_b0110","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2025.2543927","article-title":"Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy","volume":"47","author":"Chen","year":"2025","journal-title":"Ren. Fail."},{"issue":"5","key":"10.1016\/j.bcp.2026.118382_b0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2337\/db22-0680","article-title":"Metrnl alleviates lipid accumulation by modulating mitochondrial homeostasis in diabetic nephropathy","volume":"72","author":"Zhou","year":"2023","journal-title":"Diabetes"},{"issue":"24","key":"10.1016\/j.bcp.2026.118382_b0120","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118382_b0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.bcp.2026.118382_b0130","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118382_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108503","article-title":"A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy","volume":"249","author":"Ashfaq","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.118382_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108930","article-title":"Dapagliflozin has protective effects on palmitate-induced renal tubular epithelial cells by enhancing mitochondrial function and reducing oxidative stress","volume":"39","author":"Ding","year":"2025","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.bcp.2026.118382_b0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fendo.2019.00441","article-title":"Dapagliflozin attenuates renal tubulointerstitial fibrosis associated with type 1 diabetes by regulating STAT1\/TGF\u03b21 signaling","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.bcp.2026.118382_b0150","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/dom.13441","article-title":"Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats","volume":"20","author":"Jaikumkao","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.118382_b0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41419-025-07396-4","article-title":"REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy","volume":"16","author":"Sunilkumar","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118382_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106659","article-title":"Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome","volume":"188","author":"Urbanek","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118382_b0165","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-020-2544-7","article-title":"Sodium-glucose cotransporter 2 inhibition suppresses HIF-1\u03b1-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice","volume":"11","author":"Cai","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118382_b0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/IJNRD.S103784","article-title":"Rodent models of diabetic nephropathy: their utility and limitations","volume":"9","author":"Kitada","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.bcp.2026.118382_b0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2019.02.042","article-title":"Renalase attenuates mitochondrial fission in cisplatin-induced acute kidney injury via modulating sirtuin-3","volume":"222","author":"Huang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118382_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122108","article-title":"Melatonin attenuates cellular senescence and apoptosis in diabetic nephropathy by regulating STAT3 phosphorylation","volume":"332","author":"Fang","year":"2023","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118382_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118382_b0190","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1038\/s41467-020-16312-7","article-title":"Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118382_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2025.10.019","article-title":"Targeting cellular senescence in diabetic kidney disease: potential of regenerative, cell-based therapies and other senotherapeutic approaches","author":"Patel","year":"2026","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bcp.2026.118382_b0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306010","article-title":"Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension","volume":"117","author":"Xiao","year":"2015","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118382_b0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"15","key":"10.1016\/j.bcp.2026.118382_b0210","doi-asserted-by":"crossref","first-page":"E3388","DOI":"10.1073\/pnas.1722452115","article-title":"S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy","volume":"115","author":"Rizza","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118382_b0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ebiom.2017.03.020","article-title":"Mitochondria in cell senescence: is mitophagy the weakest link?","volume":"21","author":"Korolchuk","year":"2017","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.bcp.2026.118382_b0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2015.11.011","article-title":"Mitochondrial dysfunction induces senescence with a distinct secretory phenotype","volume":"23","author":"Wiley","year":"2016","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.bcp.2026.118382_b0225","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gl\u00fcck","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"7329","key":"10.1016\/j.bcp.2026.118382_b0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2026.118382_b0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2018.9","article-title":"Mitochondrial dysfunction in diabetic kidney disease","volume":"14","author":"Forbes","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118382_b0240","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1172\/JCI127277","article-title":"Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice","volume":"129","author":"Galvan","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcp.2026.118382_b0245","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI77632","article-title":"Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury","volume":"125","author":"Morigi","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bcp.2026.118382_b0250","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41374-018-0176-7","article-title":"STC-1 ameliorates renal injury in diabetic nephropathy by inhibiting the expression of BNIP3 through the AMPK\/SIRT3 pathway","volume":"99","author":"Liu","year":"2019","journal-title":"Lab. Invest."},{"issue":"7","key":"10.1016\/j.bcp.2026.118382_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011707","article-title":"Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis","volume":"5","author":"Kong","year":"2010","journal-title":"PLoS One"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:26:30Z","timestamp":1791908790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226007215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"alternative-id":["S0006295226007215"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118382","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin attenuates cellular senescence and mitochondrial dysfunction in diabetic kidney disease: potential involvement of AMPK\/Sirt3 signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118382"}}